Back to dashboard
Episode 673
DIP Ep 673: USMLE Pharm Crash Course, The Drugs That Matter (Part 4)
Pharmacology
Hard
5 - Very High
High Yield
Step 1Step 2Step 3COMLEX
PHARMACOLOGYCHEMOTHERAPYIMMUNOSUPPRESSIONANTIDOTESTOXICOLOGY
Topic
Chemotherapy, Immunosuppressants & High-Yield Toxicities / Antidotes; Antimetabolites (Methotrexate, 5-FU, 6-MP); Alkylating Agents & Cross-linkers (Cyclophosphamide, Cisplatin); Anthracyclines (Doxorubicin); Microtubule inhibitors (Vincristine vs Vinblastine, Paclitaxel); Calcineurin Inhibitors (Tacrolimus, Cyclosporine); High-yield Board Antidotes & Rescue Agents.
Key Takeaway
Chemotherapy and antidote board questions are paired: know the mechanism of toxicity and its specific chemoprotective rescue agent. Cyclophosphamide hemorrhagic cystitis is prevented with Mesna; Doxorubicin cardiotoxicity is prevented with Dexrazoxane; Methotrexate myelosuppression is rescued with Leucovorin; and Cisplatin nephrotoxicity is mitigated with Amifostine.
Runtime: 33.5 min
Published: 2026-09-18
System: Pharmacology
Section: PHARMACOLOGY, ONCOLOGY, TOXICOLOGY
Episode Notes
Source / episode info
- Episode: 673
- Title: DIP Ep 673: USMLE Pharm Crash Course, The Drugs That Matter (Part 4)
- Published: 2026-09-18
- Source: DIP Ep 673: USMLE Pharm Crash Course, The Drugs That Matter (Part 4)
One-liner
The concluding chapter of the Pharmacology Crash Course covers antineoplastic classes, cell-cycle specificity, organ-specific chemotoxicities and their rescue antidotes, immunosuppressants, and universal board poison antidotes.
High-yield summary
- Antimetabolites (S-Phase Specific): Methotrexate inhibits dihydrofolate reductase (DHFR); causes myelosuppression, hepatotoxicity, and pulmonary fibrosis; rescued by Leucovorin (folinic acid bypasses DHFR). 5-Fluorouracil (5-FU) inhibits thymidylate synthase; enhanced by leucovorin (unlike MTX!); causes myelosuppression and hand-foot syndrome. 6-Mercaptopurine (6-MP) and Azathioprine are metabolized by xanthine oxidase; co-administration with allopurinol leads to massive toxic accumulation and fatal pancytopenia (requires 75% dose reduction).
- DNA Alkylating & Cross-Linking Agents: Cyclophosphamide cross-links DNA at guanine N-7; metabolized to acrolein which causes severe hemorrhagic cystitis and bladder transitional cell carcinoma; prevented with aggressive hydration and MESNA (2-mercaptoethanesulfonate binds acrolein). Cisplatin & Carboplatin cross-link DNA; cause nephrotoxicity (acute tubular necrosis) and ototoxicity (acoustic nerve damage); prevented with Amifostine (free radical scavenger) and aggressive chloride diuresis.
- Microtubule Inhibitors (M-Phase Specific): Vincristine and Vinblastine bind beta-tubulin and prevent microtubule polymerization. "Vincristine crisps the nerves" (peripheral sensorimotor neuropathy, paralytic ileus). "Vinblastine blasts the marrow" (severe bone marrow suppression). Paclitaxel and docetaxel hyper-stabilize microtubules, preventing depolymerization.
- Organ-Specific Chemotherapy Toxicities: Anthracyclines (Doxorubicin, Daunorubicin) generate iron-mediated free radicals, causing dilated cardiomyopathy and congestive heart failure; prevented with Dexrazoxane (iron chelator). Bleomycin causes pulmonary fibrosis and hyperpigmentation (along with Busulfan and Methotrexate). Trastuzumab (anti-HER2) causes reversible cardiotoxicity (decreased ejection fraction without myocyte necrosis, unlike anthracyclines).
- Calcineurin Inhibitors: Tacrolimus (binds FKBP-12) and Cyclosporine (binds cyclophilin) inhibit calcineurin, preventing NFAT dephosphorylation and blocking IL-2 transcription. Both are nephrotoxic (afferent arteriolar vasoconstriction). Cyclosporine uniquely causes gingival hyperplasia and hirsutism. Sirolimus (Rapamycin) inhibits mTOR, preventing response to IL-2; causes pancytopenia and hyperlipidemia, but is NOT nephrotoxic ("kidney-sparing").
- High-Yield Poison Antidotes: Acetaminophen -> N-acetylcysteine (restores hepatic glutathione). Beta-blockers -> Glucagon (stimulates adenylate cyclase independent of beta receptors). Carbon monoxide -> 100% O2 / Hyperbaric oxygen. Cyanide -> Hydroxocobalamin or Sodium Nitrite + Sodium Thiosulfate. Heparin -> Protamine sulfate. Warfarin -> Vitamin K + 4-factor Prothrombin Complex Concentrate (PCC). Methanol / Ethylene glycol -> Fomepizole (inhibits alcohol dehydrogenase). Organophosphates -> Atropine + Pralidoxime. Opioids -> Naloxone. Benzodiazepines -> Flumazenil.
Learning objectives
- Pair chemotherapeutic agents with their organ-specific toxicities and corresponding chemoprotective antidotes.
- Explain the drug interaction between azathioprine/6-MP and allopurinol.
- Differentiate the mechanism and side effect profiles of Tacrolimus, Cyclosporine, and Sirolimus.
- Select the appropriate clinical antidote for common toxicology ingestions on Step 2, Step 3, and COMLEX.
- Distinguish reversible (Trastuzumab) from irreversible (Doxorubicin) chemotherapeutic cardiotoxicity.
Board exam buzzwords
| Chemo Agent / Toxin | Primary Mechanism | Characteristic Organ Toxicity | Specific Antidote / Rescue |
|---|---|---|---|
| Cyclophosphamide | Alkylates DNA, generates acrolein metabolite | Hemorrhagic cystitis, bladder cancer | MESNA + vigorous intravenous hydration. |
| Doxorubicin | Free radical generation & topoisomerase II inhibition | Dilated cardiomyopathy (congestive heart failure) | Dexrazoxane (iron-chelating free-radical scavenger). |
| Methotrexate | Inhibits dihydrofolate reductase (DHFR) | Myelosuppression, mucositis, pulmonary fibrosis | Leucovorin (folinic acid). Glucarpidase in severe acute renal failure. |
| Cisplatin | DNA cross-linking (platinum analog) | Nephrotoxicity, ototoxicity, peripheral neuropathy | Amifostine + aggressive IV saline diuresis. |
| Bleomycin | Free radical DNA strand breaks | Pulmonary fibrosis, hyperpigmentation | Monitor DLCO; cumulative lifetime dose cap. |
| Ethylene Glycol | Metabolized by alcohol dehydrogenase to oxalic acid | Anion-gap metabolic acidosis, envelope-shaped oxalate crystals in urine, AKI | Fomepizole (competitive inhibitor of alcohol dehydrogenase). |
Rapid review table
| Toxin / Drug Overdose | Antidote of Choice | Mechanism of Antidote |
|---|---|---|
| Acetaminophen | N-acetylcysteine (NAC) | Replenishes hepatic glutathione; binds toxic NAPQI metabolite |
| Beta-blocker overdose | Glucagon | Activates Gs protein-coupled receptor, increasing cAMP independent of beta-1 receptors |
| Heparin toxicity | Protamine sulfate | Positively charged peptide binds and neutralizes negatively charged heparin |
| Warfarin major bleed | 4-Factor PCC + IV Vitamin K | Rapidly replaces vitamin K-dependent clotting factors (II, VII, IX, X, Protein C & S) |
| Methanol / Ethylene Glycol | Fomepizole | Competitively inhibits alcohol dehydrogenase, preventing toxic acid metabolite formation |
| Cyanide toxicity | Hydroxocobalamin | Binds cyanide with high affinity to form nontoxic cyanocobalamin (Vitamin B12), excreted in urine |
Board-speak -> diagnosis
| Vignette Clue | Target Concept / Diagnosis | Why It Fits |
|---|---|---|
| Vignette Clue | Underlying Pharmacologic Pathology | Correct Clinical Action |
| Gout patient on allopurinol started on azathioprine for Crohn disease presents with severe fever, mouth sores, and absolute neutrophil count of 120 /mcL. | Xanthine oxidase inhibition by allopurinol blocks 6-MP breakdown, causing catastrophic pancytopenia. | Stop drugs immediately; administer G-CSF (filgrastim) and broad-spectrum empiric antibiotics. |
| Breast cancer patient on doxorubicin develops orthopnea, paroxysmal nocturnal dyspnea, and EF drop from 60% to 32%. | Doxorubicin-induced free-radical myocyte necrosis and myofibrillar dropout. | Discontinue doxorubicin; initiate standard heart failure guideline-directed medical therapy. |
| Renal transplant recipient on tacrolimus and mycophenolate develops rising creatinine from 1.1 to 2.3 mg/dL without rejection on biopsy. | Calcineurin inhibitor-induced renal afferent arteriolar vasoconstriction. | Check trough tacrolimus level; reduce dosage to restore normal glomerular hemodynamics. |
Management pearls
- Trastuzumab (Herceptin) cardiotoxicity is "Type II" (stunned myocardium without myocyte destruction, dose-independent, reversible upon stopping). Anthracycline cardiotoxicity is "Type I" (myocyte death with vacuolization, cumulative dose-dependent, irreversible).
- In ethylene glycol ingestion, wood lamp examination of urine can reveal fluorescence because commercial antifreeze contains sodium fluorescein dye.
- Flumazenil can precipitate acute withdrawal seizures in benzodiazepine-dependent patients or in mixed overdoses with tricyclic antidepressants. Use extreme caution!
Don't miss
🚨 Azathioprine + Allopurinol Lethal Interaction: If a question mentions starting azathioprine or 6-MP in a patient taking allopurinol or febuxostat, the dose MUST be reduced by 75%, or severe fatal bone marrow aplasia will occur.
🚨 Leucovorin in MTX vs 5-FU: Leucovorin RESCUES bone marrow in methotrexate toxicity by bypassing DHFR. However, in 5-FU therapy, leucovorin ENHANCES the cytotoxic efficacy of 5-FU by stabilizing the thymidylate synthase complex.
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics & Biomechanics for COMLEX candidates:
- Hepatic and biliary viscerosomatic reflexes: T5–T9 sympathetics on the right side. In patients undergoing hepatotoxic chemotherapy (methotrexate, azathioprine), palpatory tissue changes along the right thoracic paraspinal region correlate with hepatic stress.
- Lymphatic drainage: Normalizing somatic dysfunction at the thoracic inlet and rib cage ensures optimal thoracic duct flow, which is vital for clearing tissue edema and metabolites in patients recovering from toxic insults.